Open access · CC-BY
via OpenAlex
Nicotinamide Riboside and NAD+ Decline: Hype vs. Evidence
Novel Techniques in Nutrition & Food Science · 2025
Deregulated nutrient-sensing
Mitochondrial dysfunction
Chronic inflammation
Human
Preclinical / animal
Review
Abstract
Nicotinamide riboside (NR), a precursor to Nicotinamide Adenine Dinucleotide (NAD+), has emerged as a popular anti-aging supplement due to its role in cellular energy metabolism and sirtuin activation.Preclinical studies in model organisms demonstrate that NR supplementation can counteract agerelated NAD+ decline, improving mitochondrial function, reducing inflammation and extending lifespan.However, human clinical trials reveal only modest benefits-such as enhanced muscle endurance and mild cardiometabolic improvements-with limitations including short study durations, small sample sizes and potential industry bias.While NR appears safe at doses up to 2,000mg/day, concerns persist about its long-term effects and overstated commercial claims.This review critically evaluates the translational gap between animal data and human outcomes, emphasizing the need for rigorous, independent research to validate NR's anti-aging potential.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.31031/ntnf.2025.08.000692
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Guth, M.A.S. (2025). Nicotinamide Riboside and NAD+ Decline: Hype vs. Evidence. <em>Novel Techniques in Nutrition & Food Science</em>. https://doi.org/10.31031/ntnf.2025.08.000692
Vancouver
Guth MAS. Nicotinamide Riboside and NAD+ Decline: Hype vs. Evidence. Novel Techniques in Nutrition & Food Science. 2025. doi:10.31031/ntnf.2025.08.000692.
BibTeX
@article{michael2025Nicoti,
title = {Nicotinamide Riboside and NAD+ Decline: Hype vs. Evidence},
author = {Michael A. S. Guth},
journal = {Novel Techniques in Nutrition & Food Science},
year = {2025},
doi = {10.31031/ntnf.2025.08.000692},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Sports Medicine 2022
Open access · CC-BY
NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans
Geromedicine 2025
Open access · CC-BY
Clinical evidence for the use of NAD+ precursors to slow aging
Chemical Research in Toxicology 2024
Open access · CC-BY
Nicotinamide riboside Induced Energy Stress and Metabolic Reprogramming in BEAS-2B Cells
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics 2020
Open access · OA
Potential significance of NAD+ biology translational research in super-aged Japan
Circulation 2017
Open access · OA
Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
npj Metabolic Health and Disease 2025
Open access · CC-BY